Alterity Therapeutics Ltd Stock: price and insider trades · United States
1 insider bought €21k of shares over the last 90 days, the latest by Marks Peter Ashley, filed 08 Sept 2026.
Alterity Therapeutics Ltd: what insiders have been doing
Alterity Therapeutics Ltd has a thin disclosure history in our data (latest filing: 8 September 2026). New filings will appear here as soon as they are published. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -47.8%Entry US$4.50 · Close 21 Oct 2026 US$2.35
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended June 2026 · cache
- 47,620 shares@ US$0.500.052% mcap100.0% of flowOrdinary sharesSEC:0002127888-26-000004:0Canonical exit: 29 Nov 2026 (T+90)
1 of 1 declaration
About Alterity Therapeutics Ltd
Alterity Therapeutics Ltd is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on NASDAQ.
